GBLB

Groupe Bruxelles Lambert S.A. (GBLB)

Market Closed
12 Dec, 15:30
XWBO XWBO
74. 05
+0.65
+0.89%
- Market Cap
25.14 P/E Ratio
2.75% Div Yield
0 Volume
8.95 Eps
73.4
Previous Close
Day Range
73.65 74.1
Year Range
62 78.6
Want to track GBLB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

GBLB closed Friday higher at €74.05, an increase of 0.89% from Thursday's close, completing a monthly decrease of -0.6% or €0.45. Over the past 12 months, GBLB stock gained 11.86%.
GBLB is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 9 different exchanges and in various currencies, with the primary listing on XWBO (EUR).

GBLB Chart

Groupe Bruxelles Lambert S.A. (GBLB) FAQ

What is the stock price today?

The current price is €74.05.

On which exchange is it traded?

Groupe Bruxelles Lambert S.A. is listed on XWBO.

What is its stock symbol?

The ticker symbol is GBLB.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.75%.

What is its market cap?

As of today, no market cap data is available.

Has Groupe Bruxelles Lambert S.A. ever had a stock split?

No, there has never been a stock split.

Groupe Bruxelles Lambert S.A. Profile

Capital Markets Industry
Financials Sector
Count Emile Quevrin CEO
XWBO Exchange
- ISIN
BE Country
69 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Groupe Bruxelles Lambert SA, established in 1902, is a renowned investment company based in Brussels, Belgium. It focuses on acquiring significant holdings in a diverse range of industrial, consumer goods, and business service companies. With operations stretching from Belgium to various European countries, North America, and internationally, the company has a broad geographic footprint. Its investment approach is characterized by a strategic selection of companies operating across different sectors, aiming to generate sustainable returns. Groupe Bruxelles Lambert SA structures its operations through seven distinct segments: Holding, Imerys, Webhelp, Canyon, Affidea, Sanoptis, and GBL Capital and Sienna Investment Managers, each catering to specific market needs and sectors.

Products and Services

  • Holding

    This segment involves the strategic management and administration of the company’s investments, focusing on long-term value creation and maintaining a diversified investment portfolio.

  • Imerys

    Through its Imerys segment, Groupe Bruxelles Lambert SA invests in a world leader specialized in mineral-based specialty solutions for industry. Imerys provides a wide range of products that contribute to improving the performance of its clients' products and processes.

  • Webhelp

    Webhelp represents the company’s investment in a global leader in business process outsourcing (BPO), particularly in customer experience and payment services. This segment leverages technology and human expertise to deliver exceptional customer engagement and business solutions.

  • Canyon

    The Canyon segment consists of investments in companies leading in their respective fields, focusing on sectors such as technology, media, telecommunications, and healthcare, aiming to drive innovation and growth.

  • Affidea

    Affidea is a leading provider of advanced diagnostic imaging, outpatient, and cancer care services. GBL's investment in Affidea underscores its commitment to healthcare excellence and accessible patient care.

  • Sanoptis

    Through Sanoptis, Groupe Bruxelles Lambert SA invests in a network of eye clinics and practices, emphasizing quality eye care services. This includes preventative eye health as well as advanced treatments and surgeries.

  • GBL Capital and Sienna Investment Managers

    This segment is dedicated to the company's asset management activities, offering innovative investment solutions and strategies to institutions, family offices, and high-net-worth individuals globally.

Contact Information

Address: Avenue Marnix 24
Phone: 32 2 289 17 17